Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Investigator-Initiated Phase 2a, Open-Label Study to Evaluate the Safety and Efficacy of CGRP Antagonists in Patients With Dry Eye Disease and Asthenopia

NCT05895500 is registered in ClinicalTrials.gov with Nvision Laser Eye Centers as lead sponsor.

NCT NCT05895500
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05895500 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Investigator-Initiated Phase 2a, Open-Label Study to Evaluate the Safety and Efficacy of CGRP Antagonists in Patients With Dry Eye Disease and Asthenopia
Lead sponsor
Nvision Laser Eye Centers
Phase
Observational
Overall status
Completed
Start date
May 10, 2023
Completion date
November 9, 2023
Enrollment
103 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthenopia, dry eye